Index | Ligand Name | Structure | PDB code | Compound Potency nM |
1 | 5vc | Crystal Structure of Aurora A Kinase Domain Bound to MK-5108 | 5ew9 | 0.01 |
2 | eml | Aurora A Kinase complexed with SCH 1473759 | 3myg | 0.02 |
3 | hpm | Aurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitor | 2c6e | 0.8 |
4 | 0c6 | Aurora A in complex with YL5-81-1 | 3uok | 0.8 |
5 | zzl | Aurora-A Inhibitor Structure | 2wtv | 1.8 |
6 | l0g | Structure determination of Aurora Kinase in complex with inhibitor | 2w1g | 3 |
7 | 0c7 | Aurora A in complex with SO2-162 | 3uol | 3.1 |
8 | ak8 | Structure of AuroraA with pyridyl-pyrimidine urea inhibitor | 3efw | 4 |
9 | 0fy | Synthesis and SAR Studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off target kinase selectivity | 3vap | 4 |
10 | y3m | SAR156497 an exquisitely selective inhibitor of Aurora kinases | 4uyn | 4 |
11 | 45b | Aurora A in complex with a bisanilinopyrimidine | 3h0z | 4.3 |
12 | zzl | STRUCTURE OF AURORA A IN COMPLEX WITH MLN8054 | 2x81 | 5 |
13 | 4rj | Human Aurora A catalytic domain bound to FK1141 | 4ztr | 5 |
14 | vx6 | Crystal structure of Aurora A in complex with VX-680 and TPX2 | 3e5a | 5.9 |
15 | l0f | Structure determination of Aurora Kinase in complex with inhibitor | 2w1f | 5.9 |
16 | 48b | Aurora A in complex with a bisanilinopyrimidine | 3h0y | 6 |
17 | fh3 | Aurora A kinase bound to a highly selective imidazopyridine inhibitor | 4byi | 9 |
18 | x6d | Aurora-A bound to an inhibitor | 2x6d | 12 |
19 | l0e | Structure determination of Aurora Kinase in complex with inhibitor | 2w1e | 12 |
20 | 0c4 | Aurora A in complex with RPM1722 | 3uoh | 13 |
21 | 627 | Structure of Aurora-2 in complex with PHA-739358 | 2j50 | 13 |
22 | 0by | Aurora A in complex with YL5-083 | 3uo6 | 15 |
23 | vek | Complex of Aurora-A bound to an Imidazopyridine-based inhibitor | 4b0g | 15 |
24 | 0bz | Aurora A in Complex with RPM1679 | 3unz | 16 |
25 | d37 | Design, synthesis, and biological evaluation of pyrazolopyridine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (Part I) | 3r22 | 17 |
26 | ak1 | Crystal structure of mouse Aurora A (Asn186->Gly, Lys240->Arg, Met302->Leu) in complex with 1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)-ethyl]- thiazol-2-yl}-3-(3-trifluoromethyl-phenyl)-urea | 3d14 | 22 |
27 | wph | Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules | 4jbo | 24 |
28 | 4rk | Human Aurora A catalytic domain bound to FK1142 | 4zts | 25 |
29 | mpy | Aurora-2 T287D T288D complexed with PHA-680632 | 2bmc | 27 |
30 | 0k6 | Structure of Aurora A mutant bound to Biogenidec cpd 15 | 4dhf | 28 |
31 | 400 | AURORA-A T288E COMPLEXED WITH PHA-828300 | 2xru | 31 |
32 | p9j | Aurora A kinase domain with phthalazinone pyrazole inhibitor | 3p9j | 31 |
33 | mmh | Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity | 3fdn | 33 |
34 | nl4 | Aurora A kinase bound to an imidazopyridine inhibitor (14a) | 5aaf | 36 |
35 | 0bx | Aurora A in complex with YL1-038-31 | 3uo5 | 39 |
36 | 0c8 | Aurora A in complex with RPM1686 | 3up2 | 40 |
37 | yph | Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules | 4jbp | 41 |
38 | cc3 | Structural Basis for the Inhibition of Aurora A Kinase by a Novel Class of High Affinity Disubstituted Pyrimidine Inhibitors | 2np8 | 42 |
39 | aki | Crystal Structure of Aurora A Kinase complexed with inhibitor | 3m11 | 43 |
40 | 6f2 | Aurora A kinase bound to an imidazopyridine inhibitor (14b) | 5aag | 46 |
41 | cj5 | Aurora A in complex with CD532 | 4j8m | 48 |
42 | 0c3 | Aurora A in complex with RPM1693 | 3uod | 49 |
43 | 0c5 | Aurora A in complex with RPM1715 | 3uoj | 51 |
44 | 9yq | Crystal structure of Aurora-A in complex with FMF-03-145-1 (compound 2) | 5one | 52 |
45 | a0h | Structure of Aurora-A bound to a selective imidazopyrazine inhibitor | 2xng | 60 |
46 | 626 | Structure of Aurora-2 in complex with PHA-680626 | 2j4z | 65 |
47 | 2vu | Aurora A kinase domain with compound 2 (N-[1-(3-cyanobenzyl)-1H-pyrazol-4-yl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide) | 4prj | 72 |
48 | d36 | Design, synthesis, and biological evaluation of pyrazolopyridine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (Part I) | 3r21 | 180 |
49 | nhi | Aurora A in complex with YL1-038-18 | 4dea | 256 |
50 | fh5 | Aurora A kinase bound to a highly selective imidazopyridine inhibitor | 4byj | 270 |
51 | 0c0 | Aurora A in complex with RPM1680 | 3uo4 | 299 |
52 | pfq | Identification, SAR Studies and X-ray Cocrystal Analysis of a Novel Furano-pyrimidine Aurora Kinase A Inhibitor | 3k5u | 309 |
53 | 4rm | Human Aurora A catalytic domain bound to FK932 | 4ztq | 480 |
54 | 2jz | Crystal structure of aurora A in complex with TPX2 and compound 10 | 3ha6 | 2100 |
55 | fxg | Crystal structure of Aurora A complexed with an inhibitor discovered through site-directed dynamic tethering | 3daj | 2900 |
56 | jve | SAR156497 an exquisitely selective inhibitor of Aurora kinases | 4uzh | 9800 |
57 | a4w | Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | 5orl | 1.5e+004 |
58 | 9qk | Aurora A kinase in complex with 2-(3-fluorophenyl)quinoline-4-carboxylic acid and ATP | 5obj | 1.65e+004 |
59 | ofi | Crystal Structure of Aurora2 kinase in complex with a GSK3beta inhibitor | 3lau | 3e+004 |
60 | a8h | Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | 5os4 | 1.665e+006 |